Sarepta Therapeutics SG&A Expense (Quarterly) Insights

Sarepta Therapeutics Inc (SRPT)

117.06 +0.10 (+0.09%) USD | NASDAQ | Apr 23, 16:00

117.09 +0.03 (+0.03%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1997. Upgrade now.

Date	Value
December 31, 2023	131.70M
September 30, 2023	120.89M
June 30, 2023	118.56M
March 31, 2023	110.71M
December 31, 2022	120.48M
September 30, 2022	104.79M
June 30, 2022	154.32M
March 31, 2022	71.84M
December 31, 2021	78.06M
September 30, 2021	61.13M
June 30, 2021	72.35M
March 31, 2021	71.13M
December 31, 2020	86.05M
September 30, 2020	75.37M
June 30, 2020	73.69M
March 31, 2020	82.77M
December 31, 2019	81.42M
September 30, 2019	75.43M
June 30, 2019	67.39M
March 31, 2019	60.57M
December 31, 2018	62.00M
September 30, 2018	53.04M
June 30, 2018	49.38M
March 31, 2018	43.34M
December 31, 2017	34.81M

Date	Value
September 30, 2017	28.18M
June 30, 2017	33.65M
March 31, 2017	26.22M
December 31, 2016	21.03M
September 30, 2016	22.18M
June 30, 2016	17.64M
March 31, 2016	20.88M
December 31, 2015	24.33M
September 30, 2015	15.09M
June 30, 2015	12.93M
March 31, 2015	22.70M
December 31, 2014	13.92M
September 30, 2014	12.88M
June 30, 2014	12.21M
March 31, 2014	10.30M
December 31, 2013	10.40M
September 30, 2013	8.014M
June 30, 2013	7.054M
March 31, 2013	6.127M
December 31, 2012	4.869M
September 30, 2012	3.565M
June 30, 2012	2.915M
March 31, 2012	3.281M
December 31, 2011	3.884M
September 30, 2011	3.185M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

61.13M

Minimum

Sep 2021

154.32M

Maximum

Jun 2022

92.53M

Average

81.42M

Median

Dec 2019

SG&A Expense (Quarterly) Benchmarks